A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia

C.M. Zwaan, S. Söderhäll, B. Brethon, M. Luciani, C. Rizzari, R.W. Stam, E. Besse, C. Dutreix, F. Fagioli, P.A. Ho, C. Dufour, R. Pieters

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)623-627
Number of pages5
JournalBritish Journal of Haematology
Volume185
Issue number3
DOIs
Publication statusPublished - 2019

Cite this

Zwaan, C. M., Söderhäll, S., Brethon, B., Luciani, M., Rizzari, C., Stam, R. W., ... Pieters, R. (2019). A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia. British Journal of Haematology, 185(3), 623-627. https://doi.org/10.1111/bjh.15593